Unfinished DNA repair contributes to the damage and age-related loss of neurons. However, it might be possible to protect the nerve cells, which may have implications for the prevention of Parkinson’s disease.
Impaired heart function does not seem to be the reason why it takes a long time for some to recover after undergoing COVID-19.
Are you a researcher with an innovative idea based on your research that can contribute to solving an important need in society, but needs funding to develop the idea further? Check the UiO call for innovation funding within all academic fields. Application deadline: 2 September 2024.
Using MRI images, the researchers were able to see that patients who developed cognitive impairment, had changes in the brain that had occurred before the stroke.
And women with this diagnosis miss out on active treatment time because of pregnancy.
Influenza is a well-known trigger for heart disease. Strict measures to prevent the spread of the coronavirus may have contributed to less influenza, and thus fewer admissions for heart disease.
It is not necessary to tailor the medication doses to patients, at thestart of treatment, for patients to have a good effect. This is shown by a new Norwegian study led by Professor Espen A. Haavardsholm.
Liver encephalopathy is one of the diseases that claims most lives worldwide. A Norwegian study has revealed that the disease disturbs vital processes in the brain.
Protein in the blood did not have the function researchers believed in the interaction between two of the body's defence systems. Professor Tom Eirik Mollnes and colleagues thereby changed an established truth.
The findings may be important for future prevention and treatment, and are an important step towards more knowledge about the causes of bipolar disorder.
The technology, consisting of a designed variant of a natural occurring protein called super albumin, can pave the way for the development of long-acting drugs. This can have major implications for individuals suffering from haemophilia.
According to a survey following doctors over 20 years, nearly four out of ten doctors have been the target of threats from a patient during the first four years after graduation and one in seven doctors have been physically assaulted.
It is safe to be physically active outdoors without having to worry about the risk of melanoma, as long as you follow the sun safety advice, say the researchers behind a large, Norwegian study.
Health care personnel who contributed to the rescue work after the 22 July 2011 terror attacks had better mental health a year later than individuals who contributed as volunteers.
One out of ten E. coli samples contained variants that are resistant to several kinds of antibiotics. Researchers warn that we must monitor the future development of antibiotic resistance carefully.
Those who had tumours removed from their livers with keyhole surgery had fewer complications, a better quality of life and similar long-term oncologic outcomes, a new PhD thesis shows.
Grid cells are the brain’s GPS system. But do they use brain waves to gather information about speed and direction? Researchers at the University of Oslo resolved the question.
People who travel a lot account for a much greater proportion of the spread of dangerous, resistant bacteria than we previously thought.
Frode Norheim, new Associate Professor at IBMS, identifies genes that could cause serious liver disease.
The research method enables us to avoid ethical challenges in studies on mothers and children.
New findings could accelerate "on-demand" production of antibody-based drugs and vaccines.
A new study provides new insights into the curative effects of gluten-free diets in coeliac patients. Results from the proteomics-based research suggests not.
Insight into cancer cells' own first aid could help the development of a new type of treatment. Johanna Olweus and her team at the UiO (University of Oslo) and the OUS (Oslo University Hospital) are important contributors to this study, which has been published in Nature.
The Research Council has announced that the innovation award goes to founder and scientific director Agnete Fredriksen in Vaccibody.
UiO:Life Science funds 14 convergence environments that address major challenges within life sciences related to health, environment and sustainable growth. A new application round has started. Researchers from all units at UiO are welcome to participate.
